Pazopanib Catalog No.:M7809-10 suggesting potentially a long-lasting effect

suggesting potentially a long-lasting effect of S3I-201 on tumor growth

GSK2983559-active metabolite

Design and optimization of selective protein kinase C θ (PKCθ) inhibitors for the treatment of autoimmune diseases

CAS Number: 58-60-6

InChiKey: QEKGSBZKRLHQSZ-VSIGASKDSA-N

Pazopanib Catalog No.:M7809-10 suggesting potentially a long-lasting effectPazopanib is an approved drug, is a small molecule inhibitor of multiple protein tyrosine kinases with potential antineoplastic activity. Pazopanib selectively inhibits vascular endothelial growth factor receptors (VEGFR) 1, 2 and 3, c kit and platelet derived growth factor receptor (PDGF R), which may result in inhibition of angiogenesis in tumors in which these receptors are upregulated. Check for active clinical trials or closed clinical trials